Catalyst Wire Dossier Catalyst Wire Dossier

Huminsulin Profil III

insulin human · Eli Lilly and Company
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Huminsulin Profil III, covering 2016-08-02 to 2016-08-02. Get the full timeline:

Most recent: Clinical Trial Update: Pharmacokinetic (PK) Bioequivalence and Pharmacodynamics (PD) of Julphar Insulin 30/70 and Huminsulin® Profil III [Phase 1]

See pricing